Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations

Clin Vaccine Immunol. 2012 Jun;19(6):974-7. doi: 10.1128/CVI.05597-11. Epub 2012 Mar 29.

Abstract

In this case series, we describe four cases in which the use of gamma interferon release assays with purified protein derivative (PPD) as a stimulating antigen was able to demonstrate PPD-specific immune activation. This may help to improve the adequate diagnosis of (systemic) Mycobacterium bovis BCG infections after intravesical BCG instillations for bladder carcinoma.

Publication types

  • Case Reports
  • Evaluation Study

MeSH terms

  • Administration, Intravesical
  • Aged
  • Aged, 80 and over
  • Humans
  • Interferon-gamma Release Tests / methods*
  • Male
  • Middle Aged
  • Mycobacterium bovis / immunology*
  • Tuberculin* / immunology
  • Tuberculosis / diagnosis*
  • Tuberculosis / microbiology
  • Urinary Bladder Neoplasms / therapy*

Substances

  • Tuberculin